Stock Market & Financial Investment News

News Breaks March 5, 2013 08:02 EDT TEAR TearLab's traction accelerating, says Canaccord Canaccord said recent research indicates TearLab's rate of traction and utilization in ophthalmologists' offices for novel dry eye disease test is accelerating. Shares are Buy rated with an $8 price target. News For TEAR From The Last 14 Days Check below for free stories on TEAR the last two weeks. Sign up for a free trial to see the rest of the stories you've been missing. May 16, 2013 12:56 EDT TEAR TearLab initiated with an Overweight at Stephens Subscribe for More Information May 14, 2013 09:32 EDT TEAR TearLab upgraded to Buy from Neutral at Sidoti Subscribe for More Information May 13, 2013 16:11 EDT TEAR TearLab reports Q1 EPS with items (30c), consensus (12c) Subscribe for More Information Sign up for a free trial to see the rest of the stories you've been missing.